| abstract |
The invention relates to novel solid pharmaceutical compositions comprising the angiotensin II receptor antagonist telmisartan, a basic agent, a surfactant or emulsifier and a water-soluble diluent, e.g. in the form of granules or in the form of a powder, as well as solid preparations ready for oral use / ingestion, e.g. capsule and tablet compositions prepared from said pharmaceutical compositions and methods for producing said compositions and compositions using a fluidized-bed granulation process or a spray-drying process. |